lung adenocarcinoma
Intra-Tumor Heterogeneity Patterns Correlate With Survival in Lung Cancer Patients
The researchers uncovered two distinct spatial patterns within lung adenocarcinoma using both proteomic and genomic approaches.
Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients
Lilly will cover the cost of Tempus' broad-based sequencing tests for advanced non-small cell lung cancer patients to improve biomarker testing access.
Blood Lipid Mass Spectrometry Assay May Enable Early-Stage Lung Cancer Detection
Researchers in China have come up with a machine learning- and lipidomics-based strategy for detecting lung cancer early in blood samples.
The method, which uses a metabolic marker called hexokinase-2, could be developed to predict cancer patient prognosis and determine progression-free survival.
Lung Cancer Organizations to Study Epidemiologic, Genomic Causes in Young Patients
The Epidemiology of Young Lung Cancer study will build on a prior genomics study to better characterize NSCLC patients diagnosed before age 40.
Jun 18, 2020
May 30, 2019
Dec 21, 2018
Jan 11, 2017
Nov 17, 2015
Sep 10, 2015
Jan 22, 2015